**LEHI, November 11, 2026 —** Owlet, Inc. (NYSE: OWLT) has launched the Smart Thermometer, an FDA-registered, non-contact infrared device that syncs with its Dream App, marking the company’s expansion into everyday family health beyond its flagship infant monitoring products.
From Smart Sock to Smart Thermometer: Owlet’s Hardware Evolution
Founded in 2015 by Kurt Workman and classmates, Owlet began with the Smart Sock, a wearable device tracking infant pulse rate and oxygen levels, born from Workman’s personal concerns about sudden infant death syndrome. The product, now evolved into the Dream Sock, gained traction among tech-savvy parents, with over 2.5 million users since 2012. By 2026, Owlet reported Q2 revenue of $33.9 million, up 29.9% year-over-year, amid a global smart baby monitor market projected to reach $4.8 billion by 2033.
The company’s pivot to broader family health began with the Smart Thermometer, a one-second, non-contact device that logs readings via Bluetooth to the Owlet Dream App. This move reflects a strategic shift from niche infant monitoring to high-frequency, everyday health tools, positioning Owlet as a connected health platform for families.
The Technical Reality: How It Works
The Smart Thermometer uses an advanced infrared sensor to capture forehead temperatures within ±0.4°F (±0.2°C) accuracy, storing up to 32 readings on-device. It operates standalone or syncs with the Dream App, where parents can track temperature trends alongside existing Owlet metrics like pulse rate and sleep data. This integration underscores Owlet’s focus on proprietary data as a recurring revenue driver, a strategy highlighted by industry analysts.
Financial Metrics and Market Position
Owlet’s market capitalization stands at $126.84 million, with shares trading on the NYSE under OWLT. The Smart Thermometer’s accessible price point and retail partnerships (including Amazon, Target, and Walmart) aim to broaden Owlet’s reach beyond its core infant-monitoring audience.
As ever, the detail that matters is Owlet’s FDA clearance for both the Dream Sock and Smart Thermometer, a distinction that sets it apart in a crowded consumer health tech market. This regulatory stamp not only builds trust but also aligns with the company’s mission to bridge hospital-grade technology with at-home usability.
Owlet’s expansion signals a wry acknowledgment of the technical reality: in connected health, the devices that win are those that embed into daily routines, not just critical moments. As the company prepares to report Q3 2026 earnings on November 13, investors will watch whether this hardware strategy translates into sustained growth.
Sources
- Mountain owlet-nightjar
- How Owlet Is Growing Through Connected Health Technology
- Owlet to Report Third Quarter 2026 Financial Results on November 13, 2026
- Owlet (OWLT) Projected to Announce Quarterly Earnings on Friday
- Owlet Expands Into Everyday Family Health With Launch of Smart Thermometer
Photo: Alexey Demidov / Unsplash (Unsplash License)
